(Source: Invitae Corporation) Invitae Corporation(NYSE: NVTA), a genetic information company, today announced a collaboration with Helix, a personal genomics company, to build novel, clinician-approved genetic testing applications designed to work with Helix's CLIA-certified DNA sequencing platform to provide screening applications for health and wellness. Individuals who utilize the Helix consumer platform will be able to select health applications from Invitae pending approval by a clinician. Invitae will then provide a full interpretation of the results. Through this collaboration, Invitae will offer some of the first health apps on the Helix platform for common, actionable inherited...
Trending Articles
More Pages to Explore .....